In vitro, the application of the STAT3 ODN-decoy to treat the malignant U251 and A172 glioma cells resulted in cell proliferation inhibition, cell cycle arrest at the G0/G1 phase, and induction of cell apoptosis. This evidence concerns the gene STAT3 and central nervous system cancer.